WBB Securities Revenue and Competitors

Location

N/A

Total Funding

Fintech

Industry

Estimated Revenue & Valuation

  • WBB Securities's estimated annual revenue is currently $2.5M per year.(i)
  • WBB Securities's estimated revenue per employee is $91,000

Employee Data

  • WBB Securities has 27 Employees.(i)
  • WBB Securities grew their employee count by 4% last year.

WBB Securities's People

NameTitleEmail/Phone
1
Chief Compliance OfficerReveal Email/Phone
2
managing director (consultant)Reveal Email/Phone
3
President/Managing PartnerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$163.9M5753%N/AN/A
Add Company

What Is WBB Securities?

Headquartered in San Diego, CA and Clark, NJ, WBB Securities, LLC is a full-service, independent broker/dealer and registered investment adviser that is known for its insightful Investment Research & Banking covering biomedical, medical device, and life science firms. WBB's focus is to provide independent financial advisors with the tools and support necessary to serve their clients in a dynamic business environment. WBB has branches throughout the United States.. Founded in 2001, WBB remains privately-held to ensure that we continue to provide independent financial advisors with solutions-oriented, full-service operations, compliance, insurance support and the private-client experience in a low-cost platform. We serve ethical, entrepreneurial-minded financial advisors with the tools and expertise necessary to serve their clients and thrive in an increasingly challenging marketplace. Our investment banking division specializes in financial advisory M&A services covering biotechnology, medical device, and life science firms. Our head banker, Steve Brozak, is regularly quoted and published in a variety of media, including ABC News, Bloomberg, and Forbes. Our research has garnered accolades from the Financial Times/Starmine ranking system (Pharmaceuticals in 2013). The Wall Street Journal's "Best of the Street" survey 2011 (Medical Equipment & Supplies), and the Financial Times/Starmine ranking system (Biotechnology in 2010). Member FINRA/SIPC, a Registered Investment Adviser

keywords:N/A

N/A

Total Funding

27

Number of Employees

$2.5M

Revenue (est)

4%

Employee Growth %

N/A

Valuation

N/A

Accelerator

WBB Securities News

2022-04-17 - Zacks: Analysts Expect Paratek Pharmaceuticals, Inc. (NASDAQ ...

WBB Securities raised shares of Paratek Pharmaceuticals from a “buy” rating to a “strong-buy” rating and set a $11.00 target price on the...

2022-03-22 - Biotech Stock Bottom Picks from Professional Research Analysts

... Director and Head of Healthcare Equity Research at Wedbush Securities. ... is the Managing Partner and President of WBB Securities, LLC.

2022-03-22 - SCYNEXIS, Inc. (SCYX) CEO Marco Taglietti on Q4 2021 Results - Earnings Call Transcript

Steve Brozak - WBB Securities. Kumar Raja - Brookline Capital Markets. Operator. Greetings, and welcome to the SCYNEXIS, Inc. Fourth Quarter...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$3.9M27N/AN/A
#2
$4.6M278%N/A
#3
$4.8M274%N/A
#4
$1.4M27-49%$4.8M
#5
$2.6M27-4%N/A